「Role of endogenous myosin phosphatase inhibitory protein, CPI-17 in vascular smooth muscle」の関連論文
-
心臓組織マクロファージの機械的ストレス応答機構の解析
-
Meclozine ameliorates skeletal muscle pathology and increases muscle forces in mdx mice
-
Adipolin/C1q/Tnf-related protein 12 prevents adverse cardiac remodeling after myocardial infarction
-
高齢MRP4欠損マウス網膜における遺伝子発現プロファイリングと表現型の変化
-
Corticotropin releasing hormone receptor 2 antagonist, RQ-00490721, for the prevention of pressure overload-induced cardiac dysfunction
-
Expression of a Crry/p65 is reduced in acute lung injury induced by extracellular histones
-
DPP-4 inhibitor induces FGF21 expression via sirtuin 1 signaling and improves myocardial energy metabolism
-
Enoxaparin promotes functional recovery after spinal cord injury by antagonizing PTPRσ
-
バソインヒビンの受容体、機能探索及びリン酸化プロラクチン生成機序の解明
-
Alternative therapeutic strategy for existing aortic aneurysms using mesenchymal stem cell–derived exosomes
-
Proliferin-1 Ameliorates Cardiotoxin-Related Skeletal Muscle Repair in Mice
-
HIF Prolyl Hydroxylase Inhibitor's Effects on Skeletal Muscles
-
C1q/TNF-Related Protein 9 Promotes Revascularization in Response to Ischemia via an eNOS-Dependent Manner
-
Functional adenosine triphosphate-sensitive potassium channel is required in high-carbohydrate diet-induced increase in β-cell mass
-
血管性認知障害におけるグリア細胞の病態生理学的役割の解明
-
Pristane/Hypoxia (PriHx) Mouse as a Novel Model of Pulmonary Hypertension Reflecting Inflammation and Fibrosis
-
低出力パルス波超音波治療(LIPUS)は肺高血圧症マウスの右心機能を改善する-新たな非薬物治療法としての可能性-
-
TIMP-1は消化管線維化における新たな指標となる
-
LPL/AQP7/GPD2 promotes glycerol metabolism under hypoxia and prevents cardiac dysfunction during ischemia
-
Adverse Effect of Circadian Rhythm Disorder on Reparative Angiogenesis in Hind Limb Ischemia
-
収縮型培養ヒト筋細胞系を用いたマイオカインR-spondin-3の作用機序に関する研究
-
X連鎖性好中球減少症(XLN)の病態に関する研究
-
Mesenchymal stem/stromal cells stably transduced with an inhibitor of CC chemokine ligand 2 ameliorate bronchopulmonary dysplasia and pulmonary hypertension
-
ミトコンドリア機能改善薬MA-5によるサルコペニア抑制効果の検討
-
高脂質低炭水化物食の質が心不全に与える影響の機序解明
-
多彩な効果を持つ五苓散の薬理作用に関する研究
-
低出力パルス波超音波治療(LIPUS)は血管-神経新生を促進し脳梗塞マウスモデルの機能回復を促進する
-
Absence of thyroid hormone induced delayed dendritic arborization in mouse primary hippocampal neurons through insufficient expression of brain-derived neurotrophic factor.
-
骨格筋におけるNRF2の活性化がもたらす運動機能改善効果の解明
-
腎うっ血における腎障害とイマチニブメシル酸塩による腎保護効果の検討
-
C1 inhibitor mitigates peritoneal injury in zymosan-induced peritonitis
-
Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice
-
Metabolic reprogramming in chondrocytes to promote mitochondrial respiration reduces downstream features of osteoarthritis
-
Understanding the functional role of selected bioactive compounds and altered genes on gastric carcinogenesis of the differentiated subtype using A4gnt-deficient mice model
-
2型糖尿病モデルdb/dbマウスの膵島における血管の構造的・機能的適応障害
-
Hyaluronan suppresses enhanced cathepsin K expression via activation of NF-κB with mechanical stress loading in a human chondrocytic HCS-2/8 cells
-
中枢神経損傷後の神経膠症を制御する新規Rac1-GSPT1シグナル伝達経路
-
力学的負荷による骨格筋肥大におけるPDK1の役割
-
Direct reprogramming of adult adipose-derived regenerative cells toward cardiomyocytes using six transcriptional factors
-
The discovery of PKCγ as a novel sleep-regulating element and analysis of its phosphorylation signaling.
-
Protein Kinase N Promotes Stress-Induced Cardiac Dysfunction Through Phosphorylation of Myocardin-Related Transcription Factor A and Disruption of Its Interaction With Actin
-
心臓リモデリングにおける心筋細胞由来VEGFAの役割
-
Desloratadine inhibits heterotopic ossification by suppression of BMP2-Smad1/5/8 signaling
-
Thrombin induces a temporal biphasic vascular response through the differential phosphorylation of endothelial nitric oxide synthase via protease-activated receptor-1 and protein kinase C
-
筋組織におけるジストロフィンの新たな生物学的意義に関する研究
-
高血糖状態が歯肉上皮の細胞接着に及ぼす影響
-
Zonisamide ameliorates neuropathic pain partly by suppressing microglial activation in the spinal cord in a mouse model
-
間葉系前駆細胞を介した骨格筋の過負荷応答
-
Cereblon依存的なユビキチン・プロテアソーム経路はサリドマイドの催眠作用に関与しているか
-
Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor